Summary Of Rituximab Hyaluronidase-Api-Biologics & Biosimilars

Chemical Name

Rituximab Hyaluronidase

CAS No.

7654-32-1

Molecular Formula

--

Innovator

Developer

Indication

Follicular Lymphoma; Chronic Lymphocytic Leukemia

Therapeutic Area

Oncology

Market Status

Launched

Approval Year

Patent Expiry